(ADVZ) – Press Releases
-
ADVANZ PHARMA makes key changes to senior leadership to further accelerate next phase of growth
-
ADVANZ PHARMA Corp. Limited Announces First Quarter 2021 Results
-
ADVANZ PHARMA Corp. Limited Announces Fourth Quarter and 2020 Results
-
ADVANZ PHARMA Corp. Limited Announces Agreement Of Terms To Be Acquired By Nordic Capital
-
ADVANZ PHARMA Corp. Limited Announces Third Quarter 2020 Results
-
ADVANZ PHARMA Corp. Limited Announces Release Date for Third Quarter 2020 Results
-
ADVANZ PHARMA Corp. Limited Announces Second Quarter 2020 Results
-
ADVANZ PHARMA Corp. Limited Announces Release Date for Second Quarter 2020 Results
-
ADVANZ PHARMA Corp. Limited Announces Results of Annual Meeting of Shareholders
-
ADVANZ PHARMA Corp. Limited Closes Acquisition of Specialty Pharmaceutical Company Correvio Pharma Corp.
-
ADVANZ PHARMA Corp. Limited Announces First Quarter 2020 Results
-
ADVANZ PHARMA Corp. Limited Closes Acquisition of the Rights to a Portfolio of Alprostadil Products from UCB S.A. for $83 Million
-
Correvio Reports Full Year 2019 Financial Results
-
ADVANZ PHARMA Corp. Limited Completes Voluntarily Delisting from the Toronto Stock Exchange
-
ADVANZ PHARMA Corp. Limited Announces Fourth Quarter and 2019 Results
-
ADVANZ PHARMA Corp. Limited to Acquire Specialty Pharmaceutical Company Correvio Pharma Corp.
-
ADVANZ PHARMA to Acquire Correvio
-
ADVANZ PHARMA Corp. Limited Announces Release Date for Fourth Quarter and 2019 Results
-
ADVANZ PHARMA Corp. Limited to Voluntarily Delist from the Toronto Stock Exchange
-
ADVANZ PHARMA Corp. Limited Announces Definitive Agreement to Acquire The Rights To A Portfolio Of Alprostadil Products From UCB S.A. For Approximately $84 Million
-
ADVANZ PHARMA Corp. Limited Comments on CMA Supplemental Statement of Objections Related to Hydrocortisone Tablets
-
ADVANZ PHARMA Announces Changes to its Board of Directors and Completion of its Continuance to Western Europe
-
ADVANZ PHARMA Corp. Announces Results of Special Meeting of Shareholders
-
ADVANZ PHARMA Corp. Announces Proposal to Re-domicile from Canada to Europe
-
ADVANZ PHARMA Corp. Announces Third Quarter 2019 Results
-
ADVANZ PHARMA Corp. Announces Release Date for Third Quarter 2019 Results
-
ADVANZ PHARMA Corp. Announces Second Quarter 2019 Results
-
ADVANZ PHARMA Corp. Comments on CMA Statement of Objections Related to Nitrofurantoin
-
ADVANZ PHARMA Corp. Announces Release Date for Second Quarter 2019 Results
-
ADVANZ PHARMA Corp. Announces Results of Annual Meeting of Shareholders
-
ADVANZ PHARMA Corp. Announces Non-Deal Roadshow for European-based Debt Investors
-
ADVANZ PHARMA Corp. Comments on CMA Statement of Objections Related to Prochlorperazine
-
ADVANZ PHARMA Corp. Announces First Quarter 2019 Results
-
ADVANZ PHARMA Corp. Announces Release Date for First Quarter 2019 Results
-
ADVANZ PHARMA Corp. Acquires International Rights to Two Medicines
-
ADVANZ PHARMA Corp. Acquires International Rights to Two Medicines
-
ADVANZ PHARMA Corp. Announces Fourth Quarter and Fiscal 2018 Results
-
ADVANZ PHARMA Corp. Comments on CMA Supplemental Statement of Objections
Back to ADVZ Stock Lookup